Document is current
Any future updates will be listed below
-
Authors
Efthymiou, Vasileios
Queenan, Natalia
Haas, Markus
Naegele, Saskia
Goss, Deborah
Faden, Daniel L.
- License Information
-
More Information
Article History
Received: 21 June 2023
Accepted: 17 December 2023
First Online: 8 January 2024
Disclosure
: Daniel Faden has received research funding or In-Kind funding from Bristol-Myers Squibb, Calico, Predicine, BostonGene, NeoGenomics, and has received consulting fees from Merck, Noetic, Chrysalis Biomedical Advisors, Arcadia and Focus. Vasileios Efthymiou, Natalia Queenan, Markus Haas, Saskia Naegele, and Deborah Goss have no conflicts of interest to declare in relation to this current work.
